The present invention relates broadly to producing a reagent on-board an instrument such as a laboratory instrument for treating a biological tissue sample with the reagent. The invention also relates generally to an instrument utilising a reagent produced on-board the instrument from a mixture of a concentrate and a diluent.
Immunohistochemical staining and in situ nucleic acid analysis are tools used in histological diagnosis and the study of tissue morphology. Immunohistochemical staining relies on the specific binding affinity of antibodies with epitopes in tissue samples, and the increasing availability of antibodies which bind specifically with unique epitopes present only in certain types of diseased cellular tissue. Immunohistochemical staining involves a series of treatment steps conducted on a tissue sample (typically a section) mounted on a glass slide to highlight, by selective staining, certain morphological indicators of disease states.
Typical treatment steps include pretreatment of the tissue sample to reduce non-specific binding, antibody treatment and incubation, enzyme labelled secondary antibody treatment and incubation, substrate reaction with the enzyme to produce a fluorophore or chromophore highlighting areas of the tissue sample having epitopes binding with the antibody, counterstaining, and the like. Between each treatment step, the tissue sample must be rinsed to remove unreacted residual reagent from the prior step. Most treatment steps involve a period of incubation typically conducted at ambient temperature of around 25° C. up to around 40° C., while cell conditioning steps are typically conducted at somewhat higher temperatures, e.g. 90° C. to 100° C. In-situ DNA analysis relies upon the specific binding affinity of probes (DNA binding proteins) with unique nucleotide sequences in cell or tissue samples and similarly involves a series of process steps, with a variety of reagents and process temperature requirements. Some specific reactions involve temperatures up to 120° C. to 130° C.
In these various treatment steps it is understood that no single concentration of antibody is sufficient to account for tissue variations, processing variability and tissue sample thickness. Reagents are provided in a Ready to Use (RTU) format that cannot be varied in concentration. Alternatively, concentrates are supplied and diluted to achieve a range of staining options. However, these approaches do not address increasing customer need for workflow flexibility with ease of reagent uses.
According to a first aspect of the invention there is provided an instrument utilizing a reagent, said instrument providing on-board mixing of the reagent and including:
The instrument may include one or more mixing wells located on the instrument and configured to receive the concentrate and the diluent for mixing to provide the reagent at the required concentration. In one embodiment the mixing well is formed in a sample staining module (SSM) of the instrument. The mixing well may be formed in a fixed or disposable cover member of the SSM. Alternately the mixing well may be a dedicated mixing well formed integral with the instrument.
Preferably the mixing wells are located adjacent one another for serial dilution of the concentrate with the diluent.
The chamber may be a container supplied in a sealed condition and adapted to contain a predetermined volume of the concentrate. The sealed container may include a sealing membrane arranged to contain the concentrate and an inert gas. The sealing membrane may be designed to be at least partly removed or pierced and the container is sized for addition of diluent for mixing on-board the instrument to provide the reagent at the required concentration. Alternatively or additionally the chamber comprises a plurality of the sealed containers each adapted to contain a predetermined volume of the concentrate. In this embodiment the plurality of chambers are arranged as multiple reservoirs e.g. in a blister pack. In another embodiment the chamber is a disposable or reusable probe tip containing the concentrate and adapted to fit to a dispensing probe of the instrument.
Preferably the packaging includes a stacked cartridge adapted to contain one or more columns of the plurality of concentrate capsules. In some embodiments two or more columns of the concentrate capsules are provided in the cartridge. More preferably the dispenser also comprises a reciprocating release operatively coupled to the stacked cartridge to release a lowermost of the column of capsules form the cartridge for mixing with the diluent on-board the instrument. Alternatively the packaging includes a cartridge reel adapted to contain a roll of the concentrate capsules retained in a concentrate tape configured to be dispensed from the cartridge reel. In this embodiment the concentrate tape includes two strips adhered to one another with the concentrate capsules sandwiched therebetween and adapted to be released from the concentrate tape.
Also described herein is an instrument utilising a reagent, said instrument including:
The diluent chamber may be a vacuum chamber to which the concentrate dispenser is operatively coupled wherein the concentrate is dispensed into the vacuum chamber with the assistance of vacuum pressure applied to the diluent chamber. Alternatively the concentrate dispenser may include a plunger for dispensing of the concentrate into the diluent chamber, preferably via a non-return valve. Still alternatively the concentrate dispenser may include a frangible separator which cooperates with the diluent chamber wherein rupturing of the frangible separator effects dispensing of the concentrate to the diluent chamber.
Generally the instrument is a laboratory instrument and the reagent is a high value reagent such as a molecular probe such as a nucleic acid probe or an antibody (Ab) although that need not be the case and the reagent may be a bulk reagent such as a wash fluid or buffer which is formulated on-board the instrument from concentrate and diluent. The concentrate may be in any state such as a liquid, solid, or lyophilised state.
Also described herein is a method of producing a reagent on-board an instrument, said method including the steps of:
In one embodiment the method may also comprise one or more subsequent steps of diluting the reagent with additional diluent to produce the required concentration.
Also described is packaging for use with an instrument in the on-board provision of a reagent, the packaging being adapted to contain a plurality of concentrate capsules, and configured to release each of the capsules for mixing with a diluent on-board the instrument to provide the reagent.
Also described is a container for use with an instrument in the on-board provision of a reagent, the container adapted to contain a predetermined volume of a concentrate for mixing with a diluent on-board the instrument to provide the reagent.
Also described is a cover member for use with an instrument in the on-board provision of a reagent, the cover member including a well being adapted to receive a concentrate for mixing with a diluent on-board the instrument to provide the reagent.
In order to achieve a better understanding of the nature of the present invention a preferred embodiment of an instrument utilizing a reagent will now be described, by way of example only, with reference to the accompanying drawings in which:
The instrument 70 of this aspect of the invention is a laboratory instrument for treating a biological tissue sample within the SSM with the reagent, typically a high value reagent in the form of a molecular probe such as a nucleic acid probe or an antibody (Ab). The high value reagent is produced at a desired concentration on-board the instrument 70 by mixing the concentrate such as 12 and diluent to provide the reagent at the required concentration. It is to be understood, however, that the reagent need not be “high value” and may be any concentrate that is amenable to dilution to a required concentration such as, for example, wash fluid or buffer solution which may be diluted with for example, deionised water, to a predetermined concentration suitable for e.g. treatment of the sample or washing or other use within a cover member of the SSM.
In some cases, to treat the tissue samples on the slides 73, a designated combination of reagents, e.g. higher and lesser value reagents, are required to be dispensed to a slide and in some embodiments it is desirable to achieve mixing to a predetermined concentration on-board the instrument. The fluid dispensing robot 76 is configured by the controller to dispense a plurality of reagents stored in reagent containers 80, 81 on board the instrument to the slides 73 in the slide staining modules 74.
In the embodiment of
In the embodiment of
In the embodiments of
In the embodiment of
In the embodiment of
It will be readily understood by those skilled in the art that a concentrate includes liquids of varying concentrations and for example includes high-value reagents and bulk reagents. The FTP of the earlier embodiment may thus extend to dispensing a reagent to be diluted, a diluent, other reagents, or a combination of these liquids.
The instrument according to various embodiments includes a controller configured to implement the preferred method of producing a reagent on-board the instrument. The method may be implemented via computer program code including instructions to control movement of a concentrate dispenser in, for example, dispensing a concentrate to a well of a cover member associated with a SSM as in
Now that several preferred embodiments of the invention have been described it will be apparent to those skilled in the art that the method of producing a reagent on-board an instrument together with the concentrate dispenser and associated packaging has at least the following advantages:
Those skilled in the art will appreciate that the invention described herein is susceptible to variations and modifications other than those specifically described. All such variations and modifications are to be considered within the scope of the present invention the nature of which is to be determined from the foregoing description.
Future patent applications may be filed in the United States of America on the basis of or claiming priority from the present application. It is to be understood that the following claims are provided by way of example only, and are not intended to limit the scope of what may be claimed in any such future application. Features may be added to or omitted from the claims at a later date so as to further define or re-define the invention or inventions.
This application is a continuation of U.S. application Ser. No. 17/066,094, filed Oct. 8, 2020, which is a continuation-in-part of U.S. application Ser. No. 14/653,956, filed on Jun. 19, 2015, which is the U.S. National Stage of International Application No. PCT/AU2013/001499, filed on Dec. 20, 2013, which claims the benefit of U.S. Provisional Application No. 61/745,331, filed Dec. 21, 2012, the disclosures of which are hereby incorporated by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
3819270 | Hirschfeld | Jun 1974 | A |
3955930 | Shapiro | May 1976 | A |
4044757 | McWhorter | Aug 1977 | A |
4129381 | Wied | Dec 1978 | A |
4231990 | Jottier | Nov 1980 | A |
4747685 | Suzuki | May 1988 | A |
4794806 | Nicoli | Jan 1989 | A |
4868129 | Gibbons et al. | Sep 1989 | A |
4997768 | Uffenheimer et al. | Mar 1991 | A |
5073505 | Nalette et al. | Dec 1991 | A |
5076472 | Gross | Dec 1991 | A |
5077017 | Gorin | Dec 1991 | A |
5116315 | Capozzi | May 1992 | A |
5861124 | Hosoi | Jan 1999 | A |
5882599 | Gilbert | Mar 1999 | A |
6211956 | Nicoli | Apr 2001 | B1 |
6360595 | Lin et al. | Mar 2002 | B1 |
6613286 | Braun et al. | Sep 2003 | B2 |
6746851 | Tseung et al. | Jun 2004 | B1 |
7055540 | Oka et al. | Jun 2006 | B2 |
7718435 | Bogen et al. | May 2010 | B1 |
7832293 | Hermet et al. | Nov 2010 | B2 |
7998434 | Shaw | Aug 2011 | B2 |
8142739 | Tseung et al. | Mar 2012 | B2 |
8173068 | Loeffler | May 2012 | B2 |
8348971 | Khanna | Jan 2013 | B2 |
8480651 | Abuzaina | Jul 2013 | B2 |
8932543 | Bui et al. | Jan 2015 | B2 |
9247931 | Belcheva | Feb 2016 | B2 |
10228382 | Dockrill et al. | Mar 2019 | B2 |
11561234 | Barbero-Ortega | Jan 2023 | B2 |
20040033554 | Powers | Feb 2004 | A1 |
20040037739 | Mcneely et al. | Feb 2004 | A1 |
20040182788 | Dorian | Sep 2004 | A1 |
20040228770 | Gandhi et al. | Nov 2004 | A1 |
20060013725 | Larsen | Jan 2006 | A1 |
20060121624 | Huang | Jun 2006 | A1 |
20080219890 | Lawson et al. | Sep 2008 | A1 |
20080308422 | Smith | Dec 2008 | A1 |
20090301231 | Wang | Dec 2009 | A1 |
20090305337 | Iqbal et al. | Dec 2009 | A1 |
20100240022 | Mcneely | Sep 2010 | A1 |
20100317093 | Turewicz | Dec 2010 | A1 |
20120101407 | Chan | Apr 2012 | A1 |
20120276582 | Ritzen et al. | Nov 2012 | A1 |
20120329140 | Iqbal et al. | Dec 2012 | A1 |
20130208558 | Pearcy et al. | Aug 2013 | A1 |
20140033809 | Bransky et al. | Feb 2014 | A1 |
20140358036 | Holmes | Dec 2014 | A1 |
20160199834 | Bransky et al. | Jul 2016 | A1 |
20170058245 | Shah et al. | Mar 2017 | A1 |
20170122846 | Holmes | May 2017 | A1 |
20170274376 | Nobile et al. | Sep 2017 | A1 |
20190277837 | Ran et al. | Sep 2019 | A1 |
20190293671 | Barbero-Ortega | Sep 2019 | A1 |
20200179932 | Williams et al. | Jun 2020 | A1 |
20200216840 | Tanno | Jul 2020 | A1 |
20200316599 | Shi et al. | Oct 2020 | A1 |
20200400534 | Shi et al. | Dec 2020 | A1 |
20210172967 | Begolo | Jun 2021 | A1 |
20220048031 | Chiang | Feb 2022 | A1 |
20220170068 | Noda | Jun 2022 | A1 |
20220305493 | Knapp et al. | Sep 2022 | A1 |
20230010400 | Shine et al. | Jan 2023 | A1 |
Number | Date | Country |
---|---|---|
2012006185 | Jan 2012 | WO |
Entry |
---|
Communication dated Jul. 26, 2016 from the European Patent Office in counterpart European Application No. 13865320.9. |
International Search Report for PCT/US2013/001499 dated Mar. 26, 2014. |
Number | Date | Country | |
---|---|---|---|
20240293820 A1 | Sep 2024 | US |
Number | Date | Country | |
---|---|---|---|
61745331 | Dec 2012 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 17066094 | Oct 2020 | US |
Child | 18661552 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14653956 | US | |
Child | 17066094 | US |